Palvella Therapeutics, Inc.

Q4 2025 13F Holders

Symbol
PVLA
CUSIP
697947109
Type
Equity
Class
COM
Num filings
149
Total reported value, excl. options
$1.02 B
Manager Report Date Value ($000) Shares Option Type